Ad26.Cov2.S [Recombinant]
Products in Health Canada’s databases that list Ad26.Cov2.S [Recombinant] as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 1
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 8
- Products in all
- 1
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| JCOVDEN (50000000000 VP) | 02513153 | Cancelled Post Market | Janssen Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- JCOVDENFebruary 16, 2023 · NOC 30129
- JCOVDENDecember 23, 2022 · NOC 29759
- JCOVDENDecember 12, 2022 · NOC 29696
- JCOVDENOctober 27, 2022 · NOC 29326
- JCOVDENAugust 5, 2022 · NOC 28706
- JANSSEN COVID-19 VACCINEMay 11, 2022 · NOC 28156
- JANSSEN COVID-19 VACCINEMarch 24, 2022 · NOC 27823
- JANSSEN COVID-19 VACCINENovember 23, 2021 · NOC 27082